147 related articles for article (PubMed ID: 32641930)
1. Comparative of
Abedi Gaballu F; Abbaspour-Ravasjani S; Mansoori B; Yekta R; Hamishehkar H; Mohammadi A; Dehghan G; Shokouhi B; Ghahremani Dehbokri S; Baradaran B
Iran J Pharm Res; 2019; 18(3):1168-1179. PubMed ID: 32641930
[TBL] [Abstract][Full Text] [Related]
2. Co-Delivery of erlotinib and resveratrol via nanostructured lipid Carriers: A synergistically promising approach for cell proliferation prevention and ROS-Mediated apoptosis activation.
Asadollahi L; Mahoutforoush A; Dorreyatim SS; Soltanfam T; Paiva-Santos AC; Peixoto D; Veiga F; Hamishehkar H; Zeinali M; Abbaspour-Ravasjani S
Int J Pharm; 2022 Aug; 624():122027. PubMed ID: 35850183
[TBL] [Abstract][Full Text] [Related]
3. Nanostructured Lipid Carriers Loaded with Baicalin: An Efficient Carrier for Enhanced Antidiabetic Effects.
Shi F; Wei Z; Zhao Y; Xu X
Pharmacogn Mag; 2016; 12(47):198-202. PubMed ID: 27601850
[TBL] [Abstract][Full Text] [Related]
4. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
5. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
[TBL] [Abstract][Full Text] [Related]
6. A novel strategy for encapsulating poorly soluble drug into nanostructured lipid carriers for intravenous administration.
Zhao C; Liu Y; Fan T; Zhou D; Yang Y; Jin Y; Zhang Z; Huang Y
Pharm Dev Technol; 2012; 17(4):443-56. PubMed ID: 21222507
[TBL] [Abstract][Full Text] [Related]
7. Optimization of Tilmicosin-Loaded Nanostructured Lipid Carriers Using Orthogonal Design for Overcoming Oral Administration Obstacle.
Wen J; Gao X; Zhang Q; Sahito B; Si H; Li G; Ding Q; Wu W; Nepovimova E; Jiang S; Wang L; Kuca K; Guo D
Pharmaceutics; 2021 Feb; 13(3):. PubMed ID: 33669090
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization and pharmacokinetic studies of linalool-loaded nanostructured lipid carriers.
Shi F; Zhao Y; Firempong CK; Xu X
Pharm Biol; 2016 Oct; 54(10):2320-8. PubMed ID: 26986932
[TBL] [Abstract][Full Text] [Related]
9. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
[TBL] [Abstract][Full Text] [Related]
10. Docetaxel-loaded nanostructured lipid carriers functionalized with trastuzumab (Herceptin) for HER2-positive breast cancer cells.
Varshosaz J; Davoudi MA; Rasoul-Amini S
J Liposome Res; 2018 Dec; 28(4):285-295. PubMed ID: 28826287
[TBL] [Abstract][Full Text] [Related]
11. Formulation of Lipid-Based Nanocarriers of Lacidipine for Improvement of Oral Delivery: Box-Behnken Design Optimization,
Kataria D; Zafar A; Ali J; Khatoon K; Khan S; Imam SS; Yasir M; Ali A
Assay Drug Dev Technol; 2022 Jan; 20(1):5-21. PubMed ID: 34978917
[TBL] [Abstract][Full Text] [Related]
12. Optimization of Maduramicin Ammonium-Loaded Nanostructured Lipid Carriers Using Box-Behnken Design for Enhanced Anticoccidial Effect against
Zhang Y; Zuo R; Song X; Gong J; Wang J; Lin M; Yang F; Cheng X; Gao X; Peng L; Ji H; Chen X; Jiang S; Guo D
Pharmaceutics; 2022 Jun; 14(7):. PubMed ID: 35890226
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
Dudhipala N; Janga KY; Gorre T
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
[TBL] [Abstract][Full Text] [Related]
14. Freeze-Dried Lopinavir-Loaded Nanostructured Lipid Carriers for Enhanced Cellular Uptake and Bioavailability: Statistical Optimization, in Vitro and in Vivo Evaluations.
Khan AA; Mudassir J; Akhtar S; Murugaiyah V; Darwis Y
Pharmaceutics; 2019 Feb; 11(2):. PubMed ID: 30823545
[TBL] [Abstract][Full Text] [Related]
15. Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.
Mandal B; Mittal NK; Balabathula P; Thoma LA; Wood GC
Eur J Pharm Sci; 2016 Jan; 81():162-71. PubMed ID: 26517962
[TBL] [Abstract][Full Text] [Related]
16. Nanostructured lipid carriers loaded with morellic acid for enhanced anticancer efficacy: preparation, characterization, pharmacokinetics and anticancer evaluation.
Jia B; Li S; Li L; Wang T; Chen W; Chen G
Am J Cancer Res; 2024; 14(3):1101-1120. PubMed ID: 38590403
[TBL] [Abstract][Full Text] [Related]
17. Development and optimization of transferrin-conjugated nanostructured lipid carriers for brain delivery of paclitaxel using Box-Behnken design.
Emami J; Rezazadeh M; Sadeghi H; Khadivar K
Pharm Dev Technol; 2017 May; 22(3):370-382. PubMed ID: 27689412
[TBL] [Abstract][Full Text] [Related]
18. PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer.
Zhang X; Gan Y; Gan L; Nie S; Pan W
J Pharm Pharmacol; 2008 Aug; 60(8):1077-87. PubMed ID: 18644200
[TBL] [Abstract][Full Text] [Related]
19. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
[TBL] [Abstract][Full Text] [Related]
20. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
